Verano Holdings Corp VRNO

Morningstar Rating
CA$7.49 −0.13 (1.71%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VRNO is trading within a range we consider fairly valued.
Price
CA$7.62
Fair Value
LOCK|?>bK^G
Uncertainty
LOCK|T^
1-Star Price
LOCK|.>q!!Vj%
5-Star Price
LOCK|^MD^xMZ
Economic Moat
LOCK|kn
Capital Allocation
—

Trading Information

Previous Close Price
CA$7.62
Day Range
CA$7.49–7.75
52-Week Range
CA$1.51–13.30
Bid/Ask
CA$0.00 / CA$7.90
Shares Outstanding
73.22M
Market Cap
CA$550.82M
Volume/Avg
74,619 / 46,326

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
0.48
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
3,800

Valuation

Metric
VRNO
Price/Earnings (Normalized)
—
Price/Book Value
0.58
Price/Sales
0.48
Price/Cash Flow
4.05
Price/Earnings
VRNO

Financial Strength

Metric
VRNO
Quick Ratio
1.31
Current Ratio
3.70
Interest Coverage
−3.15
Quick Ratio
VRNO

Profitability

Metric
VRNO
Return on Assets (Normalized)
−3.81%
Return on Equity (Normalized)
−8.84%
Return on Invested Capital (Normalized)
−2.09%
Return on Assets
VRNO

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|kV!BHM!vLOCK|^@$QF$67B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|BP%ft$$>LOCK|Dp<@$46B
Haleon PLC ADR
HLN
LOCK|H^hD%<<LOCK|?g!$38B
Zoetis Inc Class A
ZTS
LOCK|&wt<c>gLOCK|s^V$29B
Viatris Inc
VTRS
LOCK|jm@^n<FLOCK|yt$20B
Elanco Animal Health Inc
ELAN
LOCK|^%gLOCK|vKf$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|?Q!f^??LOCK|?L$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|fmkTS%rLOCK|$<P$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|>PLk>J#LOCK|?&tZP$2B
Perrigo Co PLC
PRGO
LOCK|>Y&%g^^LOCK|ZM$2B

Sponsor Center